Articles on Medication

Displaying 21 - 40 of 86 articles

Ensuring people have coverage for essential medications is crucial. (Shutterstock)

Pharmacare is now law in Canada, but negotiations with provinces could slow progress

Despite the historic passage of pharmacare legislation, its rollout remains uncertain. While some provinces have already reached deals with Ottawa, others remain in discussions.
Like natural hormones, known as endogenous hormones, the artificial hormones contained in the pill, known as exogenous hormones, can have effects on the brain. (Shutterstock)

The contraceptive pill also affects the brain and the regulation of emotions

Oral contraceptives modify the menstrual cycle. What’s less well known is that they also reach the brain, particularly the regions important for regulating emotions.
Under a pharmacare plan, a single bargaining agent negotiates for lower prices from drug companies. (Shutterstock)

With a pharmacare bill on the horizon, Big Pharma’s attack on single‑payer drug coverage for Canadians needs a fact check

Pharmaceutical and insurance industries that could lose profit through lower drug prices are not happy that a pharmacare bill is planned for fall. They are speaking out and mobilizing their allies.
A new study found that those with student loans are more likely to delay medical, dental and mental health care. PeopleImages/iStock via Getty Images

College students with loans more likely to report bad health and skip medicine and care, study finds

College students who postpone medical care to save money end up paying for it down the line in the form of worse health, a researcher contends.
A nurse dispenses liquid Methadose, an FDA-approved medication that helps people addicted to opioids. Whitney Hayward/Portland Press Herald via Getty Images

Myths about will power and moral weakness keep people with opioid use disorder from receiving effective medications like methadone, buprenorphine and naltrexone

Prescription medications can help people with opioid use disorder avoid the risks of relapse and overdose. But stigma based on misperceptions about addiction limits their use.
Lecanemab is an antibody that attaches to beta-amyloid proteins accumulated in the brain and allows the immune system to get rid of them. (Shutterstock)

Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

An 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild Alzheimer’s disease. But this is only the first step towards a real cure.

Top contributors

More